HRL vs NTLA · P/E 29, rev $8.96B vs rev $22.7M
Hormel Foods Corporation (HRL) versus Intellia Therapeutics Inc (NTLA) — a side-by-side from cached financials, not a winner call.
Hormel Foods Corporation (HRL) is a packaged foods company listed on NYSE.
Intellia Therapeutics Inc (NTLA) is a biotechnology company listed on US.
Latest reported HRL revenue for 2026-07-26 was $8.96B. Net income was $398.8M. Revenue was up 49.4% from 2026-04-26 to 2026-07-26. HRL currently screens at market cap $13.39B and trailing P/E 28.6.
Latest reported NTLA revenue for 2026-06-30 was $22.7M. Net income was -$202.9M. Revenue was up 50.9% from 2026-03-31 to 2026-06-30. NTLA currently screens at market cap $1.19B.
HRL currently screens at market cap $13.39B and trailing P/E 28.6. NTLA currently screens at market cap $1.19B.
Not investment advice. Open the HRL and NTLA stock pages for the full models.
Not investment advice.